// App-Quantinova.ai

E062 : Baseline characteristics of patients with rheumatoid arthritis starting the janus kinase inhibitor baricitinib: real-life observation study

Researchers

Presenter

  • May Nwe Lwin

Principal Investigators

  • Zoe Cole

  • Chris Holroyd

  • Alexandra OReilly

  • Diane Hill

  • Patrick D W Kiely

  • Christopher Edwards

Medical Centers

  • Rheumatology, University of Southampton NHS FT, Southampton, UNITED KINGDOM

  • Department of Rheumatology, Salisbury NHS Foundation Trust, Salisbury, UNITED KINGDOM

  • Rheumatology, St George's University Hospitals NHS Foundation Trust, London, United Kingdom

  • NIHR Clinical research Facility, University Hospital Southampton, Southampton, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Baricitinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved